KC7F2
Chemical Name: N,N'-(Dithiodi-2,1-ethanediyl)bis[2,5-dichlorobenzenesulfonamide
Purity: ≥98%
Biological Activity
KC7F2 is an inhibitor of HIF-1α. Thought to act via down-regulation of HIF-1α protein synthesis; reduces phosphorylation of eIF4E binding protein 1 (4EBP1) and p70 S6K in hypoxic conditions. Also blocks hypoxia-induced HIF-1α accumulation in a range of human cancer cell lines. Inhibits the expression of HIF target genes, such as carbonic anhydrase IX and MMP2.Technical Data
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Background References
-
Inhibiting the hypoxia response for cancer therapy: the new kid on the block.
Koh et al.
Clin.Cancer Res., 2009;15:5945 -
Identification of a novel small molecule HIF-1α translation inhibitor.
Narita et al.
Clin.Cancer Res., 2009;15:6128
Product Datasheets
Reconstitution Calculator
Molarity Calculator
Citations for KC7F2
The citations listed below are publications that use Tocris products. Selected citations for KC7F2 include:
2 Citations: Showing 1 - 2
-
LXR Activation Induces a Proinflammatory Trained Innate Immunity-Phenotype in Human Monocytes.
Authors: Hannes M Et al.
Front Immunol 2020;11:353
-
Lactate preconditioning promotes a HIF-1α-mediated metabolic shift from OXPHOS to glycolysis in normal human diploid fibroblasts.
Authors: Dean H Et al.
Sci Rep 2020;10:8388
FAQs
No product specific FAQs exist for this product, however you may
View all Small Molecule FAQsReviews for KC7F2
There are currently no reviews for this product. Be the first to review KC7F2 and earn rewards!
Have you used KC7F2?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image